JSE LIMITED - Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust

Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust

JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN Code: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
(“JSE”)

DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST

The JSE LTIS 2018 Trust (“Trust”) has acquired 542 982 JSE ordinary shares
in the open market on behalf of executive directors, prescribed officers,
the Company Secretary and other senior members of staff (“LTIS 2018
participants”) to fulfil share awards granted in March 2021 to these LTIS
2018 participants under the JSE’s Long-Term Incentive Scheme (“LTIS 2018”).

These ordinary shares are held in trust and are restricted until all vesting
criteria are fulfilled whereupon the shares vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled
the share awards are forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively “the vesting criteria”).

These JSE ordinary shares were acquired on-market, with prior clearance,
at a volume-weighted average price (“VWAP”) of R120.7186 per ordinary share.
The total transaction value amounted to R65 548 026. The daily high, low
and volume-weighted average price for the various transactions effected by
the Trust were –

 Dates in 2021   Number of JSE   Daily VWAP of   Daily highest   Daily lowest
 that JSE        ordinary        JSE shares      price paid      price paid
 ordinary        shares          acquired        (cents per      (cents per
 shares were     acquired        (cents per      share)          share)
 acquired                        share)

 9 March         214 909         11838.76        11980           11638

 10 March        61 307          12131.02        12220           11975

 11 March        137 691         12230.20        12319           12138

 12 March        129 075         12262.96        12371           12189

The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these shares.

ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY

Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, the prescribed officers and the
Company Secretary have on 12 March 2021 accepted grants of restricted JSE
ordinary shares, as reflected below.


Executive       Role              Total number    Total Rand value    Nature of
                                  of restricted   of restricted JSE   interest
                                  JSE ordinary    ordinary shares
                                  shares          awarded and
                                  awarded and     accepted
                                  accepted

L Fourie        Group CEO &       82 980          10 017 230          Direct
                Executive                                             beneficial
                Director
A Takoordeen    CFO & Executive   24 210          2 922 597           Direct
                Director                                              beneficial
A Greenwood     Prescribed        26 008          3 139 649           Direct
                Officer                                               beneficial
D Khumalo       Prescribed        19 296          2 329 386           Direct
                Officer                                               beneficial
H Kotze         Prescribed        22 530          2 719 790           Direct
                Officer                                               beneficial
V Lee           Prescribed        19 988          2 412 923           Direct
                Officer                                               beneficial
I Monale        Prescribed        23 212          2 802 120           Direct
                Officer                                               beneficial
M Randall       Prescribed        21 538          2 600 037           Direct
                Officer                                               beneficial
V Reddy         Prescribed        24 824          2 996 718           Direct
                Officer                                               beneficial
GA Brookes      Group Company     11 630          1 403 957           Direct
                Secretary                                             beneficial

The restricted shares will vest in two tranches, one-half on 1 March 2024
and the remaining half on 1 March 2025, subject to the vesting criteria as
set out above being met.

The individual allocations (grant and acceptance) were approved by the JSE’s
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.

Sandton
15 March 2021

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 15-03-2021 03:28:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.